121 related articles for article (PubMed ID: 8219225)
1. The N-terminal domain of human urokinase receptor contains two distinct regions critical for ligand recognition.
Pöllänen JJ
Blood; 1993 Nov; 82(9):2719-29. PubMed ID: 8219225
[TBL] [Abstract][Full Text] [Related]
2. Binding of human single chain urokinase to Chinese Hamster Ovary cells and cloning of hamster u-PAR.
Fowler B; Mackman N; Parmer RJ; Miles LA
Thromb Haemost; 1998 Jul; 80(1):148-54. PubMed ID: 9684801
[TBL] [Abstract][Full Text] [Related]
3. Identification and characterization of the murine cell surface receptor for the urokinase-type plasminogen activator.
Solberg H; Løber D; Eriksen J; Ploug M; Rønne E; Behrendt N; Danø K; Høyer-Hansen G
Eur J Biochem; 1992 Apr; 205(2):451-8. PubMed ID: 1374026
[TBL] [Abstract][Full Text] [Related]
4. N-linked glycosylation of the ligand-binding domain of the human urokinase receptor contributes to the affinity for its ligand.
Møller LB; Pöllänen J; Rønne E; Pedersen N; Blasi F
J Biol Chem; 1993 May; 268(15):11152-9. PubMed ID: 8388383
[TBL] [Abstract][Full Text] [Related]
5. Regulation of the urokinase-type plasminogen activator receptor on vascular smooth muscle cells is under the control of thrombin and other mitogens.
Reuning U; Bang NU
Arterioscler Thromb; 1992 Oct; 12(10):1161-70. PubMed ID: 1327097
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the binding of urokinase-type plasminogen activator (u-PA) to plasminogen, to plasminogen-activator inhibitor-1 and to the u-PA receptor.
Lijnen HR; De Cock F; Collen D
Eur J Biochem; 1994 Sep; 224(2):567-74. PubMed ID: 7925373
[TBL] [Abstract][Full Text] [Related]
7. Thrombin decreases the urokinase receptor and surface-localized fibrinolysis in cultured endothelial cells.
Li XN; Varma VK; Parks JM; Benza RL; Koons JC; Grammer JR; Grenett H; Tabengwa EM; Booyse FM
Arterioscler Thromb Vasc Biol; 1995 Mar; 15(3):410-9. PubMed ID: 7749851
[TBL] [Abstract][Full Text] [Related]
8. Cellular receptor for urokinase plasminogen activator. Carboxyl-terminal processing and membrane anchoring by glycosyl-phosphatidylinositol.
Ploug M; Rønne E; Behrendt N; Jensen AL; Blasi F; Danø K
J Biol Chem; 1991 Jan; 266(3):1926-33. PubMed ID: 1846368
[TBL] [Abstract][Full Text] [Related]
9. Bovine urokinase-type plasminogen activator and its receptor: cloning and induction by retinoic acid.
Krätzschmar J; Haendler B; Kojima S; Rifkin DB; Schleuning WD
Gene; 1993 Mar; 125(2):177-83. PubMed ID: 8385052
[TBL] [Abstract][Full Text] [Related]
10. Structural requirements for glycosyl-phosphatidylinositol-anchor attachment in the cellular receptor for urokinase plasminogen activator.
Møller LB; Ploug M; Blasi F
Eur J Biochem; 1992 Sep; 208(2):493-500. PubMed ID: 1325912
[TBL] [Abstract][Full Text] [Related]
11. The ligand-binding domain of the cell surface receptor for urokinase-type plasminogen activator.
Behrendt N; Ploug M; Patthy L; Houen G; Blasi F; Danø K
J Biol Chem; 1991 Apr; 266(12):7842-7. PubMed ID: 1850423
[TBL] [Abstract][Full Text] [Related]
12. Fluorescent probes as tools to assess the receptor for the urokinase-type plasminogen activator on tumor cells.
Schmitt M; Chucholowski N; Busch E; Hellmann D; Wagner B; Goretzki L; Jänicke F; Günzler WA; Graeff H
Semin Thromb Hemost; 1991 Jul; 17(3):291-302. PubMed ID: 1724574
[TBL] [Abstract][Full Text] [Related]
13. Increase of a urokinase receptor-related low-molecular-weight molecule in colorectal adenocarcinomas.
Lau HK; Kim M; Koo J; Chiu B; Murray D
Clin Exp Metastasis; 1995 Nov; 13(6):492-8. PubMed ID: 7586807
[TBL] [Abstract][Full Text] [Related]
14. Mitogenic effects of urokinase on melanoma cells are independent of high affinity binding to the urokinase receptor.
Koopman JL; Slomp J; de Bart AC; Quax PH; Verheijen JH
J Biol Chem; 1998 Dec; 273(50):33267-72. PubMed ID: 9837898
[TBL] [Abstract][Full Text] [Related]
15. Domain-domain interactions in hybrids of tissue-type plasminogen activator and urokinase-type plasminogen activator.
Bakker AH; Nieuwenbroek NM; Verheijen JH
Protein Eng; 1995 Dec; 8(12):1295-1302. PubMed ID: 8869642
[TBL] [Abstract][Full Text] [Related]
16. Defective cell migration in an ovarian cancer cell line is associated with impaired urokinase-induced tyrosine phosphorylation.
Mirshahi SS; Lounes KC; Lu H; Pujade-Lauraine E; Mishal Z; Bénard J; Bernadou A; Soria C; Soria J
FEBS Lett; 1997 Jul; 411(2-3):322-6. PubMed ID: 9271229
[TBL] [Abstract][Full Text] [Related]
17. Proteolytically active streptococcal pyrogenic exotoxin B cleaves monocytic cell urokinase receptor and releases an active fragment of the receptor from the cell surface.
Wolf BB; Gibson CA; Kapur V; Hussaini IM; Musser JM; Gonias SL
J Biol Chem; 1994 Dec; 269(48):30682-7. PubMed ID: 7982988
[TBL] [Abstract][Full Text] [Related]
18. Generation and characterization of urokinase receptor-deficient mice.
Dewerchin M; Nuffelen AV; Wallays G; Bouché A; Moons L; Carmeliet P; Mulligan RC; Collen D
J Clin Invest; 1996 Feb; 97(3):870-8. PubMed ID: 8609247
[TBL] [Abstract][Full Text] [Related]
19. Binding of human urokinase-type plasminogen activator to its receptor: residues involved in species specificity and binding.
Quax PH; Grimbergen JM; Lansink M; Bakker AH; Blatter MC; Belin D; van Hinsbergh VW; Verheijen JH
Arterioscler Thromb Vasc Biol; 1998 May; 18(5):693-701. PubMed ID: 9598826
[TBL] [Abstract][Full Text] [Related]
20. Identification of specific sites involved in ligand binding by photoaffinity labeling of the receptor for the urokinase-type plasminogen activator. Residues located at equivalent positions in uPAR domains I and III participate in the assembly of a composite ligand-binding site.
Ploug M
Biochemistry; 1998 Nov; 37(47):16494-505. PubMed ID: 9843416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
